CEVA (NASDAQ:CEVA) & Tempus AI (NASDAQ:TEM) Head to Head Review

CEVA (NASDAQ:CEVA) and Tempus AI (NASDAQ:TEM) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, earnings, risk, valuation and dividends.

Profitability

This table compares CEVA and Tempus AI’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CEVA	-8.22%	-2.48%	-2.16%
Tempus AI	N/A	N/A	-111.38%

Analyst Ratings

This is a summary of current recommendations and price targets for CEVA and Tempus AI, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CEVA	0	0	5	0	3.00
Tempus AI	0	6	6	0	2.50

CEVA presently has a consensus target price of $36.60, suggesting a potential upside of 21.55%. Tempus AI has a consensus target price of $61.18, suggesting a potential upside of 28.26%. Given Tempus AI’s higher probable upside, analysts plainly believe Tempus AI is more favorable than CEVA.

Institutional & Insider Ownership

85.4% of CEVA shares are owned by institutional investors. Comparatively, 24.2% of Tempus AI shares are owned by institutional investors. 2.4% of CEVA shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares CEVA and Tempus AI”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CEVA	$106.94 million	6.70	-$8.79 million	($0.37)	-81.38
Tempus AI	$693.40 million	11.85	-$289.81 million	N/A	N/A

CEVA has higher earnings, but lower revenue than Tempus AI.

Summary

Tempus AI beats CEVA on 6 of the 11 factors compared between the two stocks.

About CEVA

CEVA, Inc. provides silicon and software IP solutions to semiconductor and original equipment manufacturer (OEM) companies worldwide. Its 5G mobile and infrastructure products include Ceva-XC vector digital signal processors (DSPs) for 5G handsets, 5G RAN, and general-purpose baseband processing; PentaG-RAN, an open ran platform for base station and radio; and PentaG2 – 5G NR modem platform for UE, as well as for non-handset 5G vertical markets, such as fixed wireless access, industry 4.0, robotics, and AR/VR devices. The company’s wireless IoT products comprise RivieraWaves’ Bluetooth 5dual mode and low energy platforms, RivieraWaves’ Wi-Fi platforms, ultra-wide band platforms, and Cellular IoT and RedCap platforms, as well as sense and inference processors and platforms consist of NeuPro-M neural processing unit (NPU) family; SensPro2 sensor hub AI platforms addressing imaging, vision, powertrain, and applications, including DSP processors, AI accelerators, and a software portfolio; and Ceva-BX1 and Ceva-BX2 audio AI DSPs. Its sensing and audio software comprise RealSpace spatial audio software package; WhisPro speech recognition; ClearVox, a voice front-end software package for voice-enabled devices; and CDNN, a neural network graph compiler that enables AI developers to automatically compile, optimize, and run pre-trained networks onto embedded devices. The company’s application software IP are licensed primarily to OEMs who embed it in their system on chip designs. It delivers AI DSPs and NPUs in the form of a hardware description language definition; and offers development platforms, software development kits, and software debug tools, which facilitate system design, debug, and software development. The company licenses its technology through a direct sales force. CEVA, Inc. was formerly known as ParthusCeva, Inc. and changed its name to CEVA, Inc. in December 2003. The company was incorporated in 1999 and is headquartered in Rockville, Maryland.

About Tempus AI

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.